Related Experiment Video
Updated: May 25, 2025
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
TP53 Deficiency in the Natural History of Prostate Cancer
Heidemarie Ofner1, Gero Kramer1, Shahrokh F Shariat1,2,3,4,5,6
1Department of Urology, Medical University of Vienna, 1090 Vienna, Austria.
Cancers
|February 26, 2025
Summary
TP53 mutations are common in advanced prostate cancer, driving aggressive disease and treatment resistance. Detecting these mutations aids prognosis and guides new targeted therapies for better patient outcomes.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Prostate cancer is a major cause of male mortality, especially in advanced stages.
- TP53 mutations are prevalent in many cancers, linked to poor prognosis and treatment resistance.
- Understanding TP53's role is crucial for improving prostate cancer outcomes.
Purpose of the Study:
- To review the role of TP53 mutations in prostate cancer progression and prognosis.
- To explore therapeutic strategies targeting TP53 alterations.
- To assess the clinical utility of TP53 mutation detection.
Main Methods:
- Comprehensive analysis of preclinical and clinical studies.
- Review of molecular mechanisms and clinical implications of TP53 alterations.
- Evaluation of liquid biopsy techniques for TP53 mutation detection.
Main Results:
- TP53 mutations are frequent in advanced prostate cancer, promoting genomic instability and treatment resistance.
- Liquid biopsies, like circulating tumor DNA analysis, show prognostic value for TP53 mutations.
- Novel TP53-targeted therapies show preclinical promise but need clinical validation.
Conclusions:
- TP53 mutations are critical biomarkers for prostate cancer progression and treatment response.
- Advances in detection and targeted therapies offer potential for improved patient outcomes.
- Further research is needed to integrate TP53-based strategies into clinical practice.
Related Concept Videos
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:12Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K